Aspirin and clopidogrel for psoriasis
Treatments studied
Part of Bones, joints & muscles, Skin clinical trials.
This study tests whether two common blood-thinning medicines, aspirin and clopidogrel, can help reduce inflammation and symptoms in people with psoriasis or psoriatic arthritis. If you have psoriasis or psoriatic arthritis and are not already on blood thinners, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have psoriasis or psoriatic arthritis, diagnosed by a doctor.
- You are between 18 and 89 years old.
- You have not taken any blood thinners (like aspirin or clopidogrel) in the last 14 days.
- You do not have a history of heart attack, stroke, or blocked leg arteries.
- You are not pregnant or breastfeeding, and you agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This study looks at health problems like heart disease and arthritis that are common in people with psoriasis. It aims to better understand these connections to improve care.
This study uses advanced testing to understand inflammation in people with certain chronic inflammatory diseases, such as psoriasis, psoriatic arthritis, other types of arthritis, or inflammatory bowel disease. The goal is to tailor treatment to your specific needs.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This study tests an oral medication called CBP-0276 for people with active psoriatic arthritis. It compares the new drug to a placebo to see if it helps reduce joint pain and skin symptoms.
This study tests an investigational tablet called ASC50 for plaque psoriasis. It aims to see if it is safe and works well for people with this skin condition.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.